XRCC4 and neoplasm: Mechanistically, lncRNA SBF2-AS1 acting as a competing endogenous RNA (ceRNA) for miR-151a-3p, leads to the disinhibition of its endogenous target, XRCC4, which enhances DNA lesions repair in tumor cells [81].